Clinical Trials Sponsored by Lundbeck France

Total 6139 results

University of Bordeaux
Lundbeck France

Completed

Use of Selincro and Impact on Usual Practice (USE-PACT)

Alcohol Dependence

France
Lundbeck LLC

Completed

Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome (LGS)

Lennox-Gastaut Syndrome
Lundbeck Foundation

Completed

Routine Bladder Catheterisation Through Fast-track Hip and Knee Replacement - What Are the Consequences?

Postoperative Urinary Retention

Denmark
Lundbeck LLC

Withdrawn

An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms

Infantile Spasms
Lundbeck LLC

Completed

Clobazam in Patients With Lennox-Gastaut Syndrome

Epilepsy | Epilepsy, Generalized | Seizures

United States, Belarus, India, Australia, Lithuania
Lundbeck LLC

Completed

Clobazam in Subjects With Lennox-Gastaut Syndrome

Epilepsy | Epilepsy, Generalized | Seizures

United States
Lundbeck LLC

Completed

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Psychotic Disorders | Parkinson's Disease

United States, India, Italy
Lundbeck LLC

Completed

A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy

Epilepsy
Lundbeck Foundation

Completed

Local Anesthetic in Total Knee Arthroplasty (TKA): Volume Versus Concentration

Postoperative Pain | Analgesic Efficacy

Denmark
Lundbeck LLC

Completed

Sabril Patient Registry

Infantile Spasms | Refractory Complex Partial Seizures in Adults
Lundbeck LLC

Completed

A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Adult Refractory Complex Partial Seizures

United States
University Hospital, Caen
H. Lundbeck A/S; Ministry of Health, France

Completed

Study on Cognitive Disorders of Multiple Sclerosis

Multiple Sclerosis

France
Lundbeck Canada Inc.

Completed

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia (BENDACT)

Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin's Lymphoma

Canada
Lundbeck Canada Inc.

Completed

Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine (AtWoRC)

Major Depressive Disorder

Canada
University Hospital, Lille
H. Lundbeck A/S; FeetMe; France Parkinson Association; Vaincre Parkinson

Recruiting

Markers of Disease Progression and Gait Within the Parkinsonian Population (Gait'N'Park)

Parkinson Disease

France
H. Lundbeck A/S

Not yet recruiting

A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men

Healthy Participants

United Kingdom
H. Lundbeck A/S

Recruiting

A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants

Healthy Participants

Netherlands
H. Lundbeck A/S

Recruiting

A Study Investigating Lu AG06474 in Healthy Young Participants

Healthy Participants

United States
H. Lundbeck A/S

Completed

A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab

Migraine | Migraine in Children

United States
H. Lundbeck A/S

Completed

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension (RESTORE)

Symptomatic Neurogenic Orthostatic Hypotension

United States
H. Lundbeck A/S

Terminated

Real World Effectiveness of Eptinezumab in Participants With Migraine (EVEC)

Migraine

United States
H. Lundbeck A/S

Completed

A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants

Migraine

United States
H. Lundbeck A/S

Terminated

A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy

Focal Epilepsy

United States
H. Lundbeck A/S

Terminated

Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants

Healthy Volunteers

Japan
H. Lundbeck A/S

Terminated

A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia

Fibromyalgia

United States
H. Lundbeck A/S

Completed

A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants

Healthy

United Kingdom
H. Lundbeck A/S

Terminated

Safety and Tolerability of Lu AG06479 in Healthy Young Men

Healthy

United States
H. Lundbeck A/S

Completed

Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects

Healthy

China
H. Lundbeck A/S

Completed

Study Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young Men

Healthy

Netherlands
H. Lundbeck A/S

Completed

Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women

Healthy

United States
H. Lundbeck A/S

Completed

Eptinezumab in Healthy Japanese Subjects

Healthy

Japan
H. Lundbeck A/S

Terminated

Safety and Tolerability of Lu AF95245 in Healthy Young Men

Healthy

Netherlands
H. Lundbeck A/S

Terminated

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

Alzheimer Disease

Finland, Sweden
H. Lundbeck A/S

Terminated

Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease

Alzheimer Disease

Austria, Finland, Sweden
H. Lundbeck A/S

Completed

A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy Subjects

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Bioequivalence Study of Lu AF35700

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease (STAR Extension)

Alzheimer's Disease

Germany, United States, Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Estonia, Finland, France, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Poland, Portugal, Romania, South Africa, Spain, Taiwan and more
H. Lundbeck A/S

Terminated

Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Dravet Syndrome

United States, Mexico
H. Lundbeck A/S

Terminated

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)

Stroke

Chile, United States, Belgium, Brazil, Canada, Denmark, Finland, Ireland, Italy, Mexico, Norway, South Africa, Sweden, United Kingdom
H. Lundbeck A/S

Completed

Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

Major Depressive Disorder

Finland, Germany, Estonia, Lithuania
H. Lundbeck A/S

Completed

Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)

Insomnia
H. Lundbeck A/S

Completed

Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia

Schizophrenia | Cognition

Hong Kong, Thailand, Belgium, France, Germany, Italy, Poland, Taiwan
H. Lundbeck A/S

Completed

Efficacy of Lu 31-130 in Patients With Schizophrenia

Schizophrenia

Philippines, Hong Kong, Czech Republic, France, Indonesia, Poland, Spain, Thailand
H. Lundbeck A/S

Completed

Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia

Friedreich's Ataxia

Germany, Austria, Italy
H. Lundbeck A/S

Completed

Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations

Bioequivalence Study in Healthy Subjects

Russian Federation
H. Lundbeck A/S

Withdrawn

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Dravet Syndrome

United States, Mexico
H. Lundbeck A/S

Completed

Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

Healthy Volunteers

France
H. Lundbeck A/S

Completed

Investigating the Absorption, Metabolism and Excretion (AME) of Idalopirdine

Healthy

United Kingdom
H. Lundbeck A/S

Completed

A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder (PERFORM)

Major Depressive Disorder

France
H. Lundbeck A/S

Completed

Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder

Generalized Anxiety Disorder

Chile, Argentina, Colombia, Costa Rica, Estonia, Finland, France, Hungary, Peru, Russian Federation, South Africa

3

Subscribe